| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $0 | — |
| SG&A Expense | $1.9M | +47.4% |
| Operating Income | -$1.9M | -47.4% |
| Interest Expense | $92K | +30.2% |
| Net Income | -$1.9M | -31.0% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6K | +0.0% |
| Current Assets | $10K | +0.0% |
| Total Assets | $10K | +0.0% |
| Current Liabilities | $1.4M | +19.0% |
| Total Liabilities | $1.4M | +19.0% |
| Stockholders' Equity | -$1.4M | -20.0% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$206K | +37.1% |
| Financing Cash Flow | $199K | -39.1% |